These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Time-dependent anti-amnesic effect of ACTH4-10 and desglycinamide-lysine vasopressin. Rigter H; Elbertse R; van Riezen H Prog Brain Res; 1975; 42():163-71. PubMed ID: 172961 [No Abstract] [Full Text] [Related]
5. Reversal of post-traumatic amnesia with lithium. Kline NA Psychosomatics; 1979 May; 20(5):363-4. PubMed ID: 531149 [No Abstract] [Full Text] [Related]
6. Vasopressin and physostigmine in the treatment of amnesia. Franceschi M; Tancredi O; Savio G; Smirne S Eur Neurol; 1982; 21(6):388-91. PubMed ID: 6756927 [No Abstract] [Full Text] [Related]
7. Retrograde amnesia: lack of attenuation with centrally administered adrenergic antagonists. Sternberg DB; Gold PE Physiol Behav; 1981 Sep; 27(3):551-5. PubMed ID: 6121353 [No Abstract] [Full Text] [Related]
8. [Experience with the use of posterior pituitary hormones in memory disorders of different etiology]. Akimov GA; Medvedev VI; Bakharev VD; Zagriadskiĭ PV; Stepovik NV Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(12):1787-90. PubMed ID: 6164188 [TBL] [Abstract][Full Text] [Related]
9. [Therapeutic action of vasopressin in amnesic syndromes and their possible action in depression]. Oliveros JC; Jandali MK Arch Neurobiol (Madr); 1978; 41(1):63-74. PubMed ID: 697515 [No Abstract] [Full Text] [Related]
10. Vasopressin (anti-diuretic hormone) for post encephalitic memory loss: a pilot study. Koizumi HM; Rowe M; Clark R J Clin Psychiatry; 1981 May; 42(5):217. PubMed ID: 7217029 [No Abstract] [Full Text] [Related]
11. Effects of VA-045 on learning and memory deficits in traumatic brain injury (TBI)-induced retrograde and anterograde amnesic mice. Tang YP; Noda Y; Hasegawa T; Nabeshima T Br J Pharmacol; 1997 Sep; 122(2):257-64. PubMed ID: 9313933 [TBL] [Abstract][Full Text] [Related]
12. Reduction of ECS-induced retrograde amnesia of passive avoidance conditioning after 5,7-dihydroxytryptamine median raphe nucleus lesion in the rat. Montanaro N; Dall'Olio R; Gandolfi O Neuropsychobiology; 1981; 7(2):57-66. PubMed ID: 6969865 [TBL] [Abstract][Full Text] [Related]
13. Recovery of function after brain damage: facilitation by the calcium entry blocker nimodipine. LeVere TE; Brugler T; Sandin M; Gray-Silva S Behav Neurosci; 1989 Jun; 103(3):561-5. PubMed ID: 2736070 [TBL] [Abstract][Full Text] [Related]
14. DDAVP in treatment of vasopressin-sensitive diabetes insipidus. Ward MK; Fraser TR Br Med J; 1974 Jul; 3(5923):86-9. PubMed ID: 4851464 [TBL] [Abstract][Full Text] [Related]
15. [Hypersensitivity against vasopressin and the synthetic vasopressin-analog DDAVP]. Flachsbarth F; Wilhelms E MMW Munch Med Wochenschr; 1982 May; 124(19):485-6. PubMed ID: 6810116 [No Abstract] [Full Text] [Related]
16. Can drugs halt memory loss? Kent S Geriatrics; 1981 Feb; 36(2):34-42. PubMed ID: 6778776 [No Abstract] [Full Text] [Related]
17. A vasopressin analogue in treatment of diabetes insipidus. Kauli R; Laron Z Arch Dis Child; 1974 Jun; 49(6):482-5. PubMed ID: 4850356 [TBL] [Abstract][Full Text] [Related]
18. Treatment with new synthetic analogue of vasopressin in diabetes insipidus. Nash H Arch Dis Child; 1973 Dec; 48(12):979-80. PubMed ID: 4765662 [No Abstract] [Full Text] [Related]
19. [2 consecutive gestations in a case of primary protracted lactation disorders cured with vasopressin]. Klimek R; Paradysz A Ginekol Pol; 1974 Dec; 45(12):1423-6. PubMed ID: 4435572 [No Abstract] [Full Text] [Related]
20. [Reproduction of "passive" avoidance in rats by administering pharmacologic agents]. Shabanov PD Zh Vyssh Nerv Deiat Im I P Pavlova; 1981; 31(1):158-63. PubMed ID: 6113722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]